Pending — not yet graded
“Bullish on Aurobindo Pharma Futures, recommending a buy in the ₹1,650-1,700 range with targets at ₹1,800-1,870 and a stop loss below ₹1,600. The stock is trending higher, forming new highs, and trading at lifetime highs with low leverage. The 1,600 level is critical support, and current sectoral and stock momentum suggest an uptrend.”
Jay Thakkar’s track record: 5 graded calls · 95% CI 12–77%
Aurobindo PharmaBullishCalled 02 Sep 2026
This call hasn't reached its evaluation window yet — the HIT/MISS verdict will appear here once it's graded against real price data. Save it above to find it again from your profile.